The underlying physiological mechanism may involve obesity, insulin resistance, and sarcopenia converging on a shared pro-inflammatory pathway [26], triggering an inflammatory cascade that impairs muscle metabolism and function. The gene discussed is INS; the disease is sarcopenia.